|
RescriptorDrug - Rescriptor The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Delavirdine Mesylate
Strength -
100MG
Applicant -
AGOURON
New Drug Application (NDA) Number -
020705
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 4, 1997
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Agouron Pharmaceuticals Inc
Rescriptor
Deferoxamine Mesylate 500mg/vial Injectable; Injection
Desferal 2gm/vial Injectable; Injection Desferal 500mg/vial Injectable; Injection Rescriptor 100mg Tablet; Oral Daunorubicin Hcl Eq 5mg Base/ml Injectable; Injection Daunorubicin Hcl Eq 20mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 50mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 5mg Base/ml Injectable; Injection Syncurine 1mg/ml Injectable; Injection Deferoxamine Mesylate 2gm/vial Injectable; Injection NewDrugInformation |